{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:14:48Z","timestamp":1789971288703,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.vaccine.2011.12.013","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T23:07:22Z","timestamp":1323904042000},"page":"1165-1169","source":"Crossref","is-referenced-by-count":47,"title":["Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes"],"prefix":"10.1016","volume":"30","author":[{"given":"Richard","family":"Fritz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus K.","family":"Orlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Hofmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Janecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Traweger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Perez-Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Noel","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kreil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.12.013_bib0005","series-title":"Fields virology","first-page":"1043","article-title":"Flaviviruses","author":"Burke","year":"2001"},{"key":"10.1016\/j.vaccine.2011.12.013_bib0010","series-title":"Vaccines","first-page":"841","article-title":"Tick-borne encephalitis vaccines","author":"Barrett","year":"2008"},{"issue":"S1","key":"10.1016\/j.vaccine.2011.12.013_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0264-410X(02)00812-5","article-title":"Epidemiology and ecology of TBE relevant to the production of effective vaccines","volume":"21","author":"Suss","year":"2003","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2011.12.013_bib0020","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.26.18916-en","article-title":"Tick-borne encephalitis in Europe and beyond\u2014the epidemiological situation as of 2007","volume":"13","author":"Suss","year":"2008","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.vaccine.2011.12.013_bib0025","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/515195","article-title":"Tick-borne encephalitis","volume":"28","author":"Dumpis","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.013_bib0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0264-410X(92)90376-U","article-title":"Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes","volume":"10","author":"Holzmann","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.12.013_bib0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","article-title":"Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia","volume":"80","author":"Ecker","year":"1990","journal-title":"J Gen Virol"},{"issue":"32","key":"10.1016\/j.vaccine.2011.12.013_bib0040","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1016\/S0264-410X(01)00218-3","article-title":"Evaluation of European tick-borne encephalitis virus vaccine against recent Siberain and far-eastern subtype strains","volume":"19","author":"Hayasaka","year":"2001","journal-title":"Vaccine"},{"issue":"S1","key":"10.1016\/j.vaccine.2011.12.013_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0264-410X(02)00811-3","article-title":"Tick-borne encephalitis\u2014pathogenesis, clinical course and long-term follow up","volume":"21","author":"Haglund","year":"2003","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2011.12.013_bib0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(02)00206-1","article-title":"Tick-borne encephalitis","volume":"57","author":"Gritsun","year":"2003","journal-title":"Antiviral Res"},{"issue":"43","key":"10.1016\/j.vaccine.2011.12.013_bib0055","doi-asserted-by":"crossref","first-page":"75596","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.12.013_bib0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3201\/eid1702.101487","article-title":"European subtype tick-borne encephalitis virus in Ixodes persulcatus ticks","volume":"17","author":"Jaaskelainen","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2011.12.013_bib0065","first-page":"809","article-title":"Efficacy of vaccination against tick-borne encephalitis","volume":"92","author":"Kunz","year":"1980","journal-title":"Wien Klin Wochenschrift"},{"issue":"S1","key":"10.1016\/j.vaccine.2011.12.013_bib0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2011.12.013_bib0075","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3201\/eid0906.030007","article-title":"Tick-borne encephalitis with hemorrhagic syndrome, Novosibirsk region, Russia, 1999","volume":"9","author":"Ternovoi","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2011.12.013_bib0080","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/vir.0.011437-0","article-title":"Tick-borne encephalitis virus\u2014a review of an emerging zoonosis","volume":"90","author":"Mansfield","year":"2009","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.013_bib0085","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.vaccine.2006.09.014","article-title":"Evaluation of vaccine encepur adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis virus","volume":"25","author":"Leonova","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.12.013_bib0090","doi-asserted-by":"crossref","first-page":"e7295","DOI":"10.1371\/journal.pone.0007295","article-title":"Non-hemagglutinating flaviviruses: molecular mechanisms for the emergence of new strains via adaptation to European ticks","volume":"4","author":"Khasnatinov","year":"2009","journal-title":"PLoS One"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2011.12.013_bib0095","first-page":"241","article-title":"Vaccines against tick-borne encephalitis: WHO position paper","volume":"86","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"issue":"21","key":"10.1016\/j.vaccine.2011.12.013_bib0100","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.vaccine.2009.02.069","article-title":"Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human","volume":"27","author":"Leonova","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2011.12.013_bib0105","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/infdis\/jir122","article-title":"A tick-borne encephalitis vaccine based on the European prototype strain induces broadly reacting cross-neutralizing antibodies in humans","volume":"203","author":"Orlinger","year":"2011","journal-title":"J Infect Dis"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2011.12.013_bib0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2249.1997.4311446.x","article-title":"Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages","volume":"110","author":"Kreil","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.12.013_bib0115","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1128\/JVI.72.4.3076-3081.1998","article-title":"Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein","volume":"72","author":"Kreil","year":"1998","journal-title":"J Virol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2011.12.013_bib0120","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/S0264-410X(98)00360-0","article-title":"Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization","volume":"17","author":"Chiba","year":"1999","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.12.013_bib0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0264-410X(91)90157-2","article-title":"Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine","volume":"9","author":"Klockmann","year":"1991","journal-title":"Vaccine"},{"issue":"April (19)","key":"10.1016\/j.vaccine.2011.12.013_bib0130","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1016\/j.vaccine.2010.02.092","article-title":"An inactivated West Nile Virus vaccine derived from a chemically synthesized cDNA system","volume":"28","author":"Orlinger","year":"2010","journal-title":"Vaccine"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2011.12.013_bib0135","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.vaccine.2008.10.003","article-title":"Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules","volume":"27","author":"Wittermann","year":"2009","journal-title":"Vaccine"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2011.12.013_bib0140","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1016\/j.vaccine.2006.03.061","article-title":"Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies","volume":"24","author":"Loew-Baselli","year":"2006","journal-title":"Vaccine"},{"issue":"June (29)","key":"10.1016\/j.vaccine.2011.12.013_bib0145","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1016\/j.vaccine.2010.04.047","article-title":"Comparison of immunogenicity and safety between two paediatric TBE vaccines","volume":"28","author":"Pollabauer","year":"2010","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.12.013_bib0150","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14712590903066711","article-title":"Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study","volume":"9","author":"Jilkova","year":"2009","journal-title":"Expert Opin Biol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11019360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11019360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T11:25:39Z","timestamp":1639999539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11019360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0264410X11019360"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}